Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 53, Issue 5, 2013, Pages 464-470

  Buckley, Victoria ^a   Razaghi, Abdalvahed ^b   Haber, Paul ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Sydney Local Health Network   (Australia)

^c University of Sydney   (Australia)

Author keywords

heroin dependence; infant newborn; methadone; pregnancy; substance related disorders

Indexed keywords

METHADONE;

ADULT; ARTICLE; BIRTH WEIGHT; CHILD HEALTH CARE; CONTROLLED STUDY; FAMILY SERVICE; FEMALE; GESTATIONAL AGE; HEROIN DEPENDENCE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEONATAL OUTCOME; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

HEROIN DEPENDENCE; INFANT NEWBORN; METHADONE; PREGNANCY; SUBSTANCE-RELATED DISORDERS;

ADULT; CHILD CUSTODY; FEMALE; GESTATIONAL AGE; HEROIN DEPENDENCE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; YOUNG ADULT;

EID: 84885174675     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12080     Document Type: Article

References (29)

1. AIHW. National Drug Strategy Household Survey report. Drug Statistic Series, 2011; no. 25 (Cat. no. PHE 145). Canberra: AIHW, 2010.
2. Marie Stopes International. Real Choices, Women, Contraception and Unplanned Pregnancy. Websurvey Melbourne: Marie Stopes International, 2008.
3. Chasnoff IJ,. Prenatal addiction: consequences of intrauterine exposure of opiates and non-opiate drugs. Drug Use in Pregnancy: Mother and Child. MTP Press Limited, Falcon House: Lancaster, UK, 1986; 52-63.
4. Keegan J, Parva M, Finnegan M, et al,. Addiction in pregnancy. J Addict Dis 2010; 29: 175-191.
5. Ludlow JP, Evans SF, Hulse G,. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 2004; 44: 301-306.
6. Finnegan LP,. Management of pregnant drug-dependent women. Ann N Y Acad Sci 1978; 311: 135-146.
7. Finnegan LP,. Treatment issues for opioid dependent women during the perinatal period. J Psychoactive Drugs 1991; 23: 191-202.
8. Wang EC,. Methadone treatment during pregnancy. J Obstet Gynecol Neonatal Nurs 1999; 28: 615-622.
9. Wilson GS, Desmond MM, Wait RB,. Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr 1981; 98: 716-722.
10. Burns L, Mattick RP, Lim K, Wallace C,. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-270.
11. Dashe J, Sheffield J, Olscher D, et al,. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002; 100: 1244-1249.
12. Dryden C, Young D, Hepburn M, MacTier H,. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009; 116: 665-671.
13. Lim S, Prasad MR, Samules P, et al,. High-dose methadone in pregnant women and its effects on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 2001; 200: 70-75.
14. Pizarro D, Habli M, Grier M, et al,. Higher maternal doses of methadone does not increase neonatal abstinence syndrome. J Subst Abuse Treat 2011; 40: 295-298.
15. Seligman NS, Almario CV, Hayes EJ, et al,. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr 2010; 157: 428-433.
16. Hulse GK, O'Neill G,. Methadone and the pregnant user: a matter for careful clinical consideration. Aust N Z J Obstet Gynaecol 2001; 41: 329-332.
17. Kashiwaqi M, Arlettaz R, Lauper U, et al,. Methadone maintenance program in a Swiss perinatal center: (I): management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 2005; 84: 140-144.
18. Gray TR, Choo RE, Concheiro M, et al,. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction 2010; 105: 2151-2159.
19. Hulse GK, Milne E, English DR, Holman CD,. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571-1579.
20. Jansson LM, Di Pietro JA, Elko A, et al,. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone. Drug Alcohol Depend 2012; 122: 213-219.
21. Ellwood DA, Sutherland P, Kent C, O'Connor M,. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27: 92-98.
22. Stimmel B, Adamsons K,. Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs. JAMA 1976; 235: 1121-1124.
23. Zelson C, Sook JL, Casalino M,. Neontal narcotic addiction: comparative effects of maternal intake of heroin and methadone. N Engl J Med 1973; 289: 1216.
24. Cleary BJ, Donnelly J, Strawbridge DJ, et al,. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010; 105: 2071-2084.
25. Kaltenbach K, Berghella V, Finnegan L,. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am 1998; 25: 139-151.
26. Jansson LM, Svikis D, Lee J, et al,. Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treat 1996; 13: 321-329.
27. Connaughton JF, Reeser D, Schut J, Finnegan LP,. Perinatal addiction: outcome and management. Am J Obstet Gynecol 1977; 129: 679-686.
28. Lundgren LM, Schilling RF, Fitzgerald T, et al,. Parental status of women injection drug users and entry to methadone maintenance. Subst Use Misuse 2003; 38: 1109-1131.
29. Prochaska JO, Velicer WF,. The transtheoretical model of behavior change. Am J Health Promot 1997; 12: 38-48.